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Summary Status epilepticus (SE) is a severe neurological condition that can result
in brain damage. In animals, SE is associated with cell loss and aberrant synaptogen-
esis. These pathological processes appear to be activity-dependent and may continue
after the SE has ended. We postulated that suppression of electrical activity following
SE at the site of the epileptic focus will reduce seizure-induced damage. To achieve
this goal, tetrodotoxin (TTX) was used to suppress electrical activity in the hippo-
campi bilaterally following SE. Adult rats experienced lithium—pilocarpine-induced
SE for 2 h while controls underwent sham-SE with saline injections. Starting 12 h after
the SE or sham-SE rats received either continuous TTX (1 mM) or saline infusions
through cannulas implanted in the bilateral hippocampi for 5 h daily for 4 days. TTX
resulted in significant EEG suppression and reduction in spikes and sharp waves. Rats
were sacrificed 2 weeks after SE and the brains examined for cell loss and sprouting.
Rats receiving TTX following SE had significantly more cell loss as well as a trend
towardmoremossy fiber sprouting than saline-treated rats following SE. TTX injection
in sham-SE rats caused no cell loss or mossy fiber sprouting. These results suggest that
suppression of electrical activity following SE is detrimental.
# 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Status epilepticus (SE), defined clinically as a sei-
zure that lasts longer than 30 min, is a common
neurological emergency and is associated with a
high morbidity and mortality rate.1,2 Although anti-* Corresponding author at: Neuroscience Center at Dartmouth,
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doi:10.1016/j.seizure.2008.04.004epileptic drugs are available to treat SE, a number of
patients do not respond to these conventional thera-
pies.3 This is of major concern, since a significant
number of patients with SE develop cognitive or
motor deficits, particularly if the SE lasts over
60 min.3,4
Animal models have provided insight into the
pathophysiological mechanisms responsible for SE-
induced brain injury. A sequence of short- and long-
term alterations occur following SE in animals,5—7
including neuronal loss in hippocampal fields CA1,. Published by Elsevier Ltd. All rights reserved.
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hilus.6,8—11 Accompanying this loss of neurons is
neuronal circuit rearrangement, the most notable
being the aberrant growth (sprouting) of granule
cell axons (the so-called mossy fibers) in the supra-
granular zone of the fascia dentata12,13 and infra-
pyramidale region of CA3.14 There are also marked
alterations in the functional and pharmacological
properties of glutamate neurotransmission15—17 and
GABA receptors following SE.18—20 Seizure activity
incrementally causes an indiscriminate and wide-
spread induction of LTP21,22 generated by removal of
the magnesium block of the NMDA receptor and
increase of intracellular calcium. This heightened
synaptic efficiency may be responsible for the sub-
sequent growth of aberrant new synapse formation6
and may contribute to post-SE cognitive impairment
by reducing overall hippocampal plasticity available
for information processing.23,24
Neuronal circuits are formed and modified by
activity-dependent mechanisms.25—29 For example,
tetrodotoxin (TTX), a potent sodium channel
blocker, impairs the formation of ocular dominance
columns,29 blocks the development of epileptiform
activity after undercutting the neocortex,28
decreases activity-dependent gene expression,30
and reduces the density of GABAergic terminals as
well as the frequency and amplitude of miniature
inhibitory postsynaptic currents.31 Since the
changes occurring following SE appear to be activ-
ity-dependent,6,7,32 we hypothesized that if we
could markedly suppress neuronal activity following
SE, we could reduce or eliminate post-seizure
synaptic remodeling. In this study, we suppressed
electrical activity including epileptiform activity
following SE using TTX in rats and compared the
histopathology with rats undergoing SE that did not
receive TTX.Materials and methods
Pilot study
A pilot study was performed to determine the con-
centration of TTX solution and intrahippocampal
infusion speed using 22 rats. TTX (Sigma) was admi-
nistered in a concentration range of 0.1—3.0 mM at
0.1 ml/h for a period of 4—9 h to both hippocampi.
Concentrations of less than 0.5 mM failed to sup-
press hippocampal theta activity to less than 25% of
baseline amplitudes and concentrations greater
than 1 mM resulted in a high mortality rate. We also
found TTX-induced EEG suppression beyond the
infusion period, lasting for at least 24 h. The mor-
tality rate was unacceptably high as well when theTTX infusion closely followed the pilocarpine-
induced SE. Based on these results we elected to
give 5 h continuous TTX infusions daily starting the
day following SE at a concentration of 1 mM at a rate
of 0.02—0.1 ml/h.
Surgery
Male adult Sprague—Dawley rats (300—350 g) (n = 20)
(Charles River Laboratories, Wilmington, MA) were
used in this study. After rats were anesthetized with
intraperitoneal (IP) pentobarbital (45 mg/kg), elec-
trode implantations were done under sterile condi-
tions.33 An electrode—cannula guide was placed in
the CA1 region of both hippocampi (3.8 mmposterior
to bregma, 2.5 mm lateral to midline, and 2.0 mm
below dura). The ground electrode for the EEG
recording was a skull screw placed over the cerebel-
lum. Rats were maintained on a 12/12 h light/dark
cycle and had free access to food and water. This
study followed NIH guidelines on animal care and
received approval of the Institutional Animal Care
and Use Committee of Dartmouth College.
Lithium—pilocarpine-induced SE
One week after surgery, 12 rats received an IP injec-
tion of lithiumchloride (127 mg/kg) 18 hprior to an IP
injection of pilocarpine (34 mg/kg) to induce SE using
previously described techniques.33,34 Ratsweremon-
itored closely for behavioral changes during the SE.
Due to considerablemovement artifact during the SE
we elected not to do continuous EEG recordings
during the SE. All rats progressed into stage 5 seizures
after 30 min of pilocarpine injection. Two hours after
the onset of SE, operationally defined as the onset of
intermittent forelimb and hind limb clonus, pento-
barbital (30 mg/kg) was given IP to terminate the SE.
Animals were then observed for a minimum of 4 h to
assure that the behavioral seizures ceased. Addi-
tional single doses of diazepam (5 mg/kg IP) injec-
tions were applied in one of the seven rats
subsequently placed in the SE-TTX group and one
of the four rats subsequently placed in the SE-normal
saline (NS) group when the animals had behavioral
evidence of continued seizures. Sham-SE groups
(n = 8) received equal volume injections of NS. On
the following day baseline EEG recordings were
obtained to assess interictal spike frequency of each
rat by quantifying 15 min of EEG recording during
quiet wakefulness.
TTX infusion and EEG recording
The day following SE rats were divided into SE-TTX
(n = 7) and SE-NS (n = 4) groups. The groups were
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frequency on their EEG. Sham-SE rats were ran-
domly divided into sham-SE-TTX (n = 4) and sham-
SE-NS (n = 4).
TTX (1 mM) was delivered through the cannulas in
the bilateral CA1 subregion using an infusion pump
at a speed of 0.02—0.1 ml/h. The speed of infusion
was adjusted based on the EEG changes. We con-
tinued applying TTX for 5 h beyond the time when
the EEG activity was suppressed to less than 25% of
the baseline amplitude (for most rats the infusion
resulted in EEG activity below 50 mV). The peak-to-
peak amplitude of theta activity was used as a
measure of neuronal activity. The control rat group
received NS at the same speed used for the TTX rats.
TTX and NS administrations were continued for 4
days. During the infusion, rats were closely mon-
itored for behavior changes and EEGs were recorded
for 10 min/h to assure that EEG activity was sup-
pressed.
Monopolar EEG recordings were used with the
ground screw in the skull over the cerebellum ser-
ving as the reference electrode. The EEG recordings
were performed using a differential AC amplifier (A-
M Systems Inc.). The data was digitized at 1 kHz
using a Digidata 1322A interface (Axon Instruments
Inc.) and analyzed offline with Clamfit 8.1 (Axon
Instruments Inc.).
Histology
Two weeks after SE, rats were sacrificed with a
lethal dose of sodium pentobarbital (100 mg/kg)
and perfused transcardially. Their brains were sec-
tioned and stained. Histology scores reflected the
mean score of both hippocampi of five brain sections
for each rat. Scoring was done by an investigator
blinded to treatment groups.
Timm-stained sections were analyzed for term-
inal sprouting in CA3 and the supragranular region
with a range from 0 to 5.35 A total Timm score was
obtained by averaging the CA3 and supragranular
scores.
Thionin staining was used to verify electrode and
cannula location and assess cell loss. Unbiased
stereological cell counts were performed by mod-
ifying a method we established in our lab.36 Manual
cell counting was performed in CA1, CA3 and the
hilus. A counting box of 50 mm  50 mmwas used for
cell counting with a 200 objective. Cells were
counted in a four square (100 mm2) area. The bot-
tom plane of the counting box was lined with the
bottom of CA3 pyramidal cell layer and the right
plane of the box was lined with right border of CA3
pyramidal layer. During CA1 counting, the bottom
plane of the counting box was lined with the bottomof CA1 pyramidal layer and the left lane of the box
was placed approximately 2 mm lateral to the mid-
line. For the hilus, we drew an imaginary line
between the edges of the two blades and counted
all the sparsely located cells inside the area outlined
by the two blades and the imaginary line except
cells that were tightly packed in the extension of
CA3 into the hilus.
Statistical analysis
The histology scores were evaluated with the
D’Agostino and Pearson omnibus normality test
and found to pass the normality test for a Gaussian
distribution. Cell counts and Timm scores were
compared using the ANOVA with group comparisons
using the Tukey’s multiple comparison test. Timm
scores in the SE-NS and SE-TTX were compared with
the t-test. To be considered statistical significant a
p-value of <0.05 had to be obtained.Results
Induction of SE
Systemic injection of pilocarpine produced severe
seizures progressing into SE in all rats. Initially, rats
developed head nodding and chewing followed by
intermittent forelimb and hind limb clonus. Even-
tually, all rats had rearing followed by loss of bal-
ance approximately 30 min after pilocarpine
injection. Following rearing, rats had a mixture of
stages 3—5 continuous behavioral seizures lasting
for at least 2 h. One rat died during SE. No rats died
in sham-SE groups. All rats in the study had similar
severity of seizures behaviorally.
TTX infusion
All TTX-treated rats had reduced muscle tone fol-
lowing TTX administration. The rats could groom
and walk slowly. Behavioral seizures were observed
during the first day of infusion in both the SE-TTX
and SE-NS groups as a residue phenomenon, but
were rarely seen thereafter. No changes in muscle
tone were seen in the two NS-treated groups nor
were any seizures seen in the sham-SE groups. No
rats died during the infusion period in any of the four
groups.
Hippocampal EEG activities were markedly sup-
pressed with amplitudes reduced by a mean of
68.8  4.2% of the baseline amplitude 1 h after
bilateral TTX infusion (Fig. 1). EEG amplitude was
assessed during theta rhythm. EEG activities gradu-
ally increased after the infusion stopped but
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Figure 1 Representative EEG examples of four treated
groups: (A) SE-TTX group, (B) SE-NS group, (C) sham-SE-
TTX group, and (D) sham-SE-NS group. EEGs were recorded
from the CA1 subfield of the hippocampus. Top trace
showed EEGs before TTX or NS treatment while bottom
trace recorded from same rat 5 h after TTX (1 mM) or NS
perfusion.
Figure 3 Comparison of Timm scores between the SE-
TTX and SE-NS groups. While there was a trend for greater
Timm staining scores in the TTX-treated SE rats
(2.59  0.32) than the controls (1.90  0.18), the results
did not achieve statistical significance ( p = 0.088). No
differences were seen in individual scores in the supra-
granular or CA3 regions. The two sham-SE groups had
either minimal or no Timm staining and are not displayed
in the graph.remained low throughout the 4 days of infusion.
Mean reduction prior to the next infusion in days
2—4 mornings was 51.8  7.1% of initial baseline
amplitude. Galvan et al.37 also reported that it took
about 12 days for the EEG amplitude at the infusion
site to return to normal compared to the contral-
ateral side after the TTX pump was removed. No
changes in EEG amplitude in rats receiving NS were
noted.Figure 2 Comparison of cell loss among the SE-TTX, SE-
sham, sham-TTX and sham-sham groups in CA1, CA3 and
hilus areas. In all three regions there were significant
differences between the SE groups and the sham-SE
groups with greater cell loss in the SE groups (CA1
(F = 24.53, p < 0.0001), CA3 (F = 39.33, p < 0.0001) and
the hilus (F = 24.53, p < 0.0001)). TTX when given to sham
rats did not result in cell loss. In the SE groups rats
administered TTX had significantly greater cell loss
( p < 0.05) in CA1 and CA3, and a trend to greater cell
loss in the hilus.There were differences between SE-TTX and SE-
NS rats in histology scores. In all three regions
analyzed there were significant differences in cell
loss between the two SE groups and the two sham-SE
groups with greater cell loss in the SE groups (CA1
(F = 24.53, p < 0.0001), CA3 (F = 39.33, p < 0.0001)
and the hilus (F = 24.53, p < 0.0001)) (Fig. 2). TTX
when given to sham rats did not result in cell loss. In
the SE groups, rats administered TTX had signifi-
cantly greater cell loss ( p < 0.05) in CA1 and CA3,
and a trend to greater cell loss in the hilus.
While there was a trend for greater total Timm
staining scores in the TTX-treated SE rats
(2.59  0.32) than the SE-NS group (1.90  0.18),
the results did not achieve statistical significance
(p = 0.088). Likewise, no differences were seen in
individual scores in the supragranular region or CA3
(Fig. 3). The two sham-SE groups had either minimal
or no Timm staining. Examples of the histopathology
are presented in Figs. 4 and 5.Discussion
Our rational for doing this study was that by dra-
matically reducing cerebral electrical activity fol-
lowing SE we would interrupt activity-dependent
processes that contribute to further brain damage.
Our hypothesis was shown to be incorrect. Rather
than offering protection, the findings demonstrated
that reducing electrical activity after SE actually
increased brain damage. The use of sham-SE rats
demonstrated that the TTX itself was not respon-
sible for the increased damage.
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Figure 4 Thionin staining in SE-TTX-treated and SE-NS-treated rats. Rats from both groups were subjected to 2 h of
lithium—pilocarpine SE followed by infusions of TTX (1 mM) or NS for 5 h for four consecutive days. Cell loss can be seen in
the hilus (A) of the dentate gyrus, CA3 (B), and CA1 (C) subfields of the hippocampus in both rats. The total cell loss score
in the SE-TTX-treated group was greater than in the SE-NS-treated group. Note cell loss as indicated by arrows.
Magnification of A and B: 100; C: 200.The results of this study were surprising. There
have been a number of studies that have demon-
strated beneficial effects of glutamate blockers
when administered following seizures.38—42 How-
ever, the drugs used in these studies effect primary
excitatory neurotransmission, and unlike TTX, do
not suppress electrical signaling.
TTX has been shown to reduce epileptiform activ-
ity in a model of cortical undercutting. Graber and
Prince28 isolated islands of sensorimotor cortex in
young rats (28—30-day old) and then implanted thin
sheets of polymer containing TTX or vehicle over the
lesions. Ten to 15 days later slices from control
animals without TTX had more evoked and sponta-
neous epileptiform activity than slices from animals
treated with TTX. In a subsequent study the investi-
gators showed that timing of the TTX application was
critical.43 If TTX was introduced 4 days or later afterthe isolation of the cortex no effect was seen. The
authors postulated that TTX altered activity-depen-
dent mechanisms associated with epileptogenesis,
but could not determine an exact mechanism. Only
limited parallels can be made between the cortical
isolation model and our model of SE. Graber and
Prince28,43 used a trauma model in which TTX was
directly applied to the epileptic focus. They used a
local lesionversus our systemically inducedSEmodel.
In addition, in ourmodel wewere not able to achieve
total suppression of EEG activity.
On the contrary, other authors have shown that in
cortical and hippocampal cultures blocking electri-
cal activity reversibly decreases GABA immunoreac-
tivity31,44,45 and reduces the amount of functional
inhibition received by pyramidal neurons.44 Kilman
et al.46 found that blockade of electrical activity in
cortical cultures decreased the amplitude of min-
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Figure 5 Timm staining in SE-TTX-treated and SE-NS-treated rats. Rats from both groups were subjected to 2 h of
lithium—pilocarpine SE followed by infusions of TTX (1 mM) or NS for 5 h for four consecutive days. Displaced Timm
granules (arrows) are seen in the strata oriens and pyramidale of CA3 (A and B) and in the supragranular region of the
dentate gyrus (A and C) in both rats. While there was a trend towards the SE-TTX-treated rats having more granules than
SE-NS-treated rats, the differences were not statistically significant. Magnification of A: 40; B: 100; C: 200.iature inhibitory postsynaptic current (mIPSC). This
occurred with no change in single-channel conduc-
tance but was accompanied by a reduction in the
average number of channels open during the mIPSC
peak and a reduction in the intensity of staining for
GABAA receptors at postsynaptic sites. In addition,
the number of synaptic sites that expressed detect-
able levels of GABAA receptors were decreased by
50% after activity blockade, although there was no
reduction in the total number of presynaptic con-
tacts. In addition, organotypic hippocampal slice
cultures that are chronically perfused with TTX have
a high incidence of spontaneous electrographic sei-
zures and increases in miniature excitatory postsy-
naptic current (mEPSC) frequency.47 It is also known
that the balance between excitation and inhibition
in the visual cortex can be influenced by activ-
ity.48,49 Visual deprivation for 2 days during earlylife increases by 25-fold the excitability of layer 4
pyramidal neurons.49 While activity-dependent
effects seem to have their most pronounced effects
during early development, it is possible that in the
injured brain, normal synaptic activity is necessary
for brain recovery.
In an experiment designed to prevent axonal
remodeling, Galvan et al.37 infused TTX unilaterally
into the dorsal hippocampus of rats during the
second week of life. Surprisingly, the authors found
that field potential recordings from behaving ani-
mals were dramatically altered with spontaneous,
synchronized spikes and electrographic seizures.
When TTX was administered in adult rats, no epi-
leptiform activity was seen. The findings suggested
that TTX, via reduction of electrical signaling,
resulted in a persistence of early-formed synapses.
However, the authors did not actually demonstrate
Effect of TTX suppression 643an increase in number of synapses in their study,
raising the possibility that other mechanisms caused
the epileptiform activity.
Buckmaster50 reported that prolonged TTX hippo-
campal infusion did not blockmossy fiber sprouting in
the pilocarpine SE model. TTX was continuously
pumped into the dentate gyrus for 28 days. Hilar
neuron loss was not prevented by TTX infusion and
mossy fiber sprouting was found in both TTX-treated
and vehicle-treated rats. While Buckmaster50 used a
constant infusion ratewithout EEGmonitoring during
infusion, our delivery method allow us to optimize
electrical suppression by constantly adjusting the
infusion rate of TTX based on the EEG reductions
of each rat. We wished to determine whether the
maximumsuppressionof theelectrical activity ofTTX
hadabeneficial effect. Theamplitudeswere reduced
by a mean of 68% of the baseline amplitude. Higher
infusion rates did not reduce the amplitude further
but increased the mortality rate.
Similar to what was found by Galvan et al.37, even
when the EEG was markedly depressed epileptiform
activity was present. In our pilot study total sup-
pression of electrical activity was associated with a
high mortality. Whether total suppression of activity
would have altered outcome in our study is not
known. However, to totally suppress activity in both
hippocampi over a course of 4 days would likely have
required ventilation support for the duration of the
treatment. Since there was no indication that
marked, but not total suppression, was beneficial,
it seems unlikely that such a study would show a
neuroprotective effect.
The distribution of TTX following intracranial
infusion had been studied by several investigators.
Boehnkea and Rasmusson51 infused 10 mM TTX
through a microdialysis probe into raccoon somato-
sensory cortex for 10 min at a speed of 5 ml/min.
Their result showed TTX could spread as far as
4.8 mm from the microdialysis probe. However, in
terms of significant inactivation of neuronal activity,
TTX has an effective spread of 2 mm. Galvan et al.37
used the [14C] 2-deoxy-D-glugcose (2DG) technique
for detecting cerebral glucose consumption asso-
ciated with neuronal activity and reported that TTX
hippocampal infusion was restricted to the infusion
site by measuring the reduction of 2DG uptake. The
effect of TTX was restricted to the infused hippo-
campus, up to 2 mm anterior and 1 mm posterior to
the infusion site after 2 weeks of continuous 10 mM
TTX infusion at a speed of 0.25 ml/h. In the current
study, we did not test the intrahippocampal distri-
bution rate of TTX. Based on the previous studies,
even though our delivery method was not the same
(we used 1 mM TTX with a speed of 0.02—0.1 ml/h),
TTX distribution should be restricted. However, ourTTX-treated rats had reduced muscle tone during
TTX administration so we cannot rule out the pos-
sibility that TTX distribution is different in rats with
prior status epilepticus. Additionally, we also found
that the mortality rate was unacceptably high when
the TTX infusion closely followed the pilocarpine-
induced status epilepticus. Immediately following
status rats are in a very fragile state, and are prone
to death with any pharmaceutical agent that results
in reduced activity and respiratory suppression. The
results suggest that following status epilepticus
spread of TTX is greater than in normal conditions
or that there is vascular uptake and distribution to
the brain and peripheral cholinergic system.
Our study was also limited to a histological end-
point. Whether animals treated with TTX would
have had a higher incidence or lower incidence of
developing epilepsy is not known. However, based
on the work of Routbort et al.52 in organotypic
cultures, it is likely that we would have seen more,
rather than fewer seizures following TTX due to
homeostatic responses involving enhancement of
excitatory neurotransmission and a reduction in
inhibitory neurotransmission.
Refractory status epilepticus is often treated
with doses of anesthetic agents such as sodium
pentobarbital, midazolam, or propofol that either
totally suppresses the EEG or elicits burst suppres-
sion.53 There is not yet a consensus as to how much
the EEG should be suppressed or how long the
suppression should occur.54,55 While stopping the
seizure is of paramount importance, this study,
along with others in the literature, raises concern
about the beneficial effects of long-term suppres-
sion of EEG activity following SE.Acknowledgement
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